Oct 30, 2022
Dr. Jhavery discusses results of DRCR Retina Protocol AC study which compared DME response to anti-VEGF injections in patients who received Aflibercept monotherapy vs those who started with Bevacizumab first and then switched to Aflibercept if needed.
Discussed article:
Jhaveri CD, Glassman AR, Ferris FL 3rd, Liu D,...